Non-Coding RNAs: New Dawn for Diabetes Mellitus Induced Erectile Dysfunction

Wenchao Xu; Hongyang Jiang; Jihong Liu; Hao Li

doi:10.3389/fmolb.2022.888624

Non-Coding RNAs: New Dawn for Diabetes Mellitus Induced Erectile Dysfunction

Front Mol Biosci. 2022 Jun 22:9:888624. doi: 10.3389/fmolb.2022.888624. eCollection 2022.

Authors

Wenchao Xu^{1

2}, Hongyang Jiang^{1

2}, Jihong Liu^{1

2}, Hao Li^{1

2}

Affiliations

¹ Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
² Institute of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Abstract

Erectile dysfunction (ED) is a common sexual dysfunction in males, with multifactorial alterations which consist of psychological and organic. Diabetes mellitus (DM) induced erectile dysfunction (DMED) is a disconcerting and critical complication of DM, and remarkably different from non-diabetic ED. The response rate of phosphodiesterase type 5 inhibitor (PDE5i), a milestone for ED therapy, is far from satisfactory in DMED. Unfortunately, the contributing mechanisms of DMED remains vague. Hence, It is urgent to seek for novel prospective biomarkers or targets of DMED. Numerous studies have proved that non-coding RNAs (ncRNAs) play essential roles in the pathogenesis process of DM, which comprise of long non-coding RNAs (lncRNAs) and small non-coding RNAs (sncRNAs) like microRNAs (miRNAs), PIWI-interacting RNAs (piRNAs) and circular RNAs (circRNAs). However, the implications of ncRNAs in DMED are still understudied. This review highlights the pathophysiology of DMED, summarizes identified mechanisms of ncRNAs associated with DMED and covers the topic of perspectives for ncRNAs in DMED.

Keywords: diabetes mellitus; erectile dysfunction; lncRNA; miRNA; non-coding RNA.

Publication types

Review